サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1452553

中南米の急性膵炎：2030年までの市場予測 - 地域別分析 - 提供別、病因別、エンドユーザー別

South & Central America Acute Pancreatitis Market Forecast to 2030 - Regional Analysis - by Offerings, Causes, and End User

出版日
ページ情報
英文 93 Pages
納期
即納可能 即納可能とは
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.08円
中南米の急性膵炎：2030年までの市場予測 - 地域別分析 - 提供別、病因別、エンドユーザー別
出版日: 2024年01月03日
発行: The Insight Partners
ページ情報: 英文 93 Pages
納期: 即納可能 即納可能とは
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

中南米の急性膵炎市場は2022年に2億904万米ドルと評価され、2030年には3億3,367万米ドルに達すると予測され、2022年から2030年までのCAGRは6.0%で成長すると予測されます。

急性膵炎に関する研究開発活動と啓発プログラムの増加が中南米の急性膵炎市場を後押し

急性膵炎の病因、経過、治療法を調査するため、世界的に広範な研究が行われています。国立膵臓財団（NPF）は、1プロジェクトあたり～US$50,000相当の複数の研究助成金を提供しています。現在までに、NPFは133の画期的な研究プロジェクトに500万米ドル以上を提供しています。助成金は、膵炎、膵臓がん、小児膵炎の診断および／または治療のために1年間授与されます。

さらに、急性膵炎の疫学と病態生理学を明らかにするために、いくつかの国際的な努力が続けられています。米国国立衛生研究所（NIH）の糖尿病・消化器・腎臓病研究所（NIDDK）は、急性膵炎に関するいくつかの知識ギャップを解決するために、2020年に10の臨床センターと1つのデータ調整センターからなる共同ネットワークを形成しました。このコンソーシアムは、急性膵炎後1型糖尿病コンソーシアム（T1DAPC）と呼ばれています。このように、急性膵炎に関する研究開発活動や、効果的な治療法開拓のための啓蒙プログラムは（直接的・間接的な手段を通じて）、中南米の急性膵炎市場の企業にとって大きな実りをもたらすものと期待されます。

中南米の急性膵炎市場の概要

中南米の急性膵炎市場は、ブラジル、アルゼンチン、その他中南米に区分されます。同地域における高齢者人口の増加と急性膵炎の症例増加が、同地域における中南米の急性膵炎市場の成長に拍車をかけています。急性膵炎は生命を脅かす疾患であり、特に老年人口では併存疾患や身体システムの悪化が病因となっています。ブラジル保健省によると、2030年までにブラジルの老人人口は世界第5位になると予想されています。WHOは、2050年までにブラジルの高齢者人口は300％以上増加し、全人口は30％増加すると推定しています。汎米保健機構（PAHO）によると、2022年、ブラジルの60歳以上の人口は3,000万人を超え、全人口の30％を占める。60歳以上の高齢者数は5,000万人に達し、2050年にはブラジルの総人口の24％を占めると予想されています。加齢以外にも、飲酒は急性膵炎を引き起こす可能性があります。Nature誌に掲載された論文によると、ブラジルではアルコール飲酒者全体の85.2％が多量飲酒者でした。このように、ブラジルにおけるアルコール消費の増加は、中南米の急性膵炎市場の成長にも拍車をかけています。

中南米の急性膵炎市場の収益と2030年までの予測（US$Mn）

中南米の急性膵炎市場セグメンテーション

中南米の急性膵炎市場は、提供、病因、エンドユーザー、国別にセグメント化されています。

提供に基づき、中南米の急性膵炎市場は投薬、診断、その他にセグメント化されます。診断セグメントが2022年に最大の市場シェアを占めました。

病因に基づき、中南米の急性膵炎市場は胆石、アルコール中毒、遺伝性疾患、感染症、その他に区分されます。2022年には胆石セグメントが最大の市場シェアを占めました。

エンドユーザー別に見ると、中南米の急性膵炎市場は病院、診断研究所、外来手術センター、その他に分けられます。病院セグメントが2022年に最大の市場シェアを占めました。

国別では、中南米の急性膵炎市場はブラジル、アルゼンチン、その他南米に区分されます。その他南米が2022年の中南米の急性膵炎市場シェアを独占しました。

Abbott Laboratories社、Baxter International Inc社、Boston Scientific Corp社、Fresenius Kabi AG社、GE HealthCare Technologies Inc社、Koninklijke Philips NV社、Medtronic Plc社、Samsung Healthcare社は、中南米の急性膵炎市場で事業を展開している大手企業です。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

  • 主要洞察
  • 中南米の急性膵炎市場：国別

第3章 調査手法

  • 調査範囲
  • 2次調査
  • 1次調査

第4章 中南米の急性膵炎市場情勢

第5章 中南米の急性膵炎市場：主要産業力学

  • 主な市場促進要因
    • 急性膵炎による膵がん患者の増加
    • 急性膵炎後の糖尿病罹患率の上昇
  • 主な市場抑制要因
    • 膵炎および膵がん治療の副作用
  • 主な市場機会
    • 急性膵炎に関する研究開発活動および啓発プログラムの増加
  • 今後の動向
    • 特定の急性膵炎治療の進歩
  • インパクト分析

第6章 急性膵炎市場：中南米市場分析

  • 中南米の急性膵炎市場収益、2022年～2030年

第7章 中南米の急性膵炎市場：収益と2030年までの予測：提供別

  • 市場収益シェア：2022年・2030年（%）
  • 薬剤
  • 診断
  • その他

第8章 中南米の急性膵炎市場：収益と2030年までの予測：病因別

  • 市場収益シェア：2022年・2030年（%）
  • 胆石症
  • アルコール中毒
  • 遺伝性疾患
  • 感染症
  • その他

第9章 南米急性膵炎市場：収益と2030年までの予測：エンドユーザー別

  • 市場収益シェア：2022年・2030年（%）
  • 病院
  • 診断研究所
  • 外来手術センター
  • その他

第10章 中南米の急性膵炎市場：国別分析

  • 中南米の急性膵炎市場：国別分析
  • ブラジル
  • アルゼンチン
  • その他中南米

第11章 中南米の急性膵炎市場-業界情勢

  • 中南米の急性膵炎市場における成長戦略
  • 無機的成長戦略
  • 有機的成長戦略

第12章 企業プロファイル

  • Abbott Laboratories
  • GE HealthCare Technologies Inc
  • Samsung Healthcare
  • Koninklijke Philips NV
  • Baxter International Inc
  • Medtronic Plc
  • Boston Scientific Corp
  • Fresenius Kabi AG

第13章 付録

図表

List Of Tables

  • Table 1. South & Central America Acute Pancreatitis Market Segmentation
  • Table 2. South & Central America Acute Pancreatitis Market, by Medications - Revenue and Forecast to 2030 (US$ Million)
  • Table 3. South & Central America Acute Pancreatitis Market, by Diagnosis - Revenue and Forecast to 2030 (US$ Million)
  • Table 4. Brazil: South & Central America Acute Pancreatitis Market, by Offerings - Revenue and Forecast to 2030 (US$ Million)
  • Table 5. Brazil: South & Central America Acute Pancreatitis Market, For Medications by Offerings - Revenue and Forecast to 2030 (US$ Million)
  • Table 6. Brazil: South & Central America Acute Pancreatitis Market, For Diagnosis by Offerings - Revenue and Forecast to 2030 (US$ Million)
  • Table 7. Brazil: South & Central America Acute Pancreatitis Market, by Causes - Revenue and Forecast to 2030 (US$ Million)
  • Table 8. Brazil: South & Central America Acute Pancreatitis Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 9. Argentina: South & Central America Acute Pancreatitis Market, by Offerings - Revenue and Forecast to 2030 (US$ Million)
  • Table 10. Argentina: South & Central America Acute Pancreatitis Market, For Medications by Offerings - Revenue and Forecast to 2030 (US$ Million)
  • Table 11. Argentina: South & Central America Acute Pancreatitis Market, For Diagnosis by Offerings - Revenue and Forecast to 2030 (US$ Million)
  • Table 12. Argentina: South & Central America Acute Pancreatitis Market, by Causes - Revenue and Forecast to 2030 (US$ Million)
  • Table 13. Argentina: South & Central America Acute Pancreatitis Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 14. Rest of South & Central America: South & Central America Acute Pancreatitis Market, by Offerings - Revenue and Forecast to 2030 (US$ Million)
  • Table 15. Rest of South & Central America: South & Central America Acute Pancreatitis Market, For Medications by Offerings - Revenue and Forecast to 2030 (US$ Million)
  • Table 16. Rest of South & Central America: South & Central America Acute Pancreatitis Market, For Diagnosis by Offerings - Revenue and Forecast to 2030 (US$ Million)
  • Table 17. Rest of South & Central America: South & Central America Acute Pancreatitis Market, by Causes - Revenue and Forecast to 2030 (US$ Million)
  • Table 18. Rest of South & Central America: South & Central America Acute Pancreatitis Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 19. Recent Inorganic Growth Strategies in the South & Central America Acute Pancreatitis Market
  • Table 20. Recent Organic Growth Strategies in the South & Central America Acute Pancreatitis Market
  • Table 21. Glossary of Terms, South & Central America Acute Pancreatitis Market

List Of Figures

  • Figure 1. South & Central America Acute Pancreatitis Market Segmentation, By Country
  • Figure 2. South & Central America Acute Pancreatitis Market - Key Industry Dynamics
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. South & Central America Acute Pancreatitis Market Revenue (US$ Mn), 2022 - 2030
  • Figure 5. South & Central America Acute Pancreatitis Market Revenue Share, by Offerings, 2022 & 2030 (%)
  • Figure 6. Medications: South & Central America Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 7. Diagnosis: South & Central America Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 8. Others: South & Central America Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. South & Central America Acute Pancreatitis Market Revenue Share, by Causes 2022 & 2030 (%)
  • Figure 10. Gallstones: South & Central America Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Alcoholism: South & Central America Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. Genetic Disorders: South & Central America Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. Infections: South & Central America Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. Others: South & Central America Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. South & Central America Acute Pancreatitis Market Revenue Share, by End User, 2022 & 2030 (%)
  • Figure 16. Hospitals: South & Central America Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 17. Diagnostic Laboratories: South & Central America Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Ambulatory Surgical Centers: South & Central America Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. Others: South & Central America Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 20. South & Central America Acute Pancreatitis Market, by Key Country - Revenue, 2022 (US$ Million)
  • Figure 21. South & Central America Acute Pancreatitis Market, By Key Countries, 2022 and 2030 (%)
  • Figure 22. Brazil: South & Central America Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 23. Argentina: South & Central America Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 24. Rest of South & Central America: South & Central America Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 25. Growth Strategies in the South & Central America Acute Pancreatitis Market
目次
Product Code: BMIRE00029244

The South & Central America acute pancreatitis market was valued at US$ 209.04 million in 2022 and is expected to reach US$ 333.67 million by 2030; it is estimated to grow at a CAGR of 6.0% from 2022 to 2030.

Upsurge in Number of R&D Activities and Awareness Programs on Acute Pancreatitis Fuels the South & Central America Acute Pancreatitis Market

Extensive research studies are being conducted globally to investigate the etiology, progress, and treatment of acute pancreatitis. The National Pancreas Foundation (NPF) provides multiple research grants worth ~US$ 50,000 per project. To date, the NPF has provided more than US$ 5 million for 133 ground-breaking research projects. A grant is awarded for a period of a year to diagnose and/or treat pancreatitis, pancreatic cancer, or pediatric pancreatitis.

Further, several ongoing international efforts are being made to define the epidemiology and pathophysiology of acute pancreatitis. The National Institute for Diabetes and Digestive and Kidney Diseases (NIDDK) of the National Institutes of Health (NIH), formed a collaborative network of 10 clinical centers and 1 data coordination center in 2020 to address several knowledge gaps regarding acute pancreatitis. The consortium is referred to as Type 1 Diabetes after Acute Pancreatitis Consortium (T1DAPC). Thus, R&D activities and awareness programs on acute pancreatitis for the development of effective therapies (through direct and indirect means) are expected to be highly fruitful for companies in the South & Central America acute pancreatitis market.

South & Central America Acute Pancreatitis Market Overview

The South & Central America acute pancreatitis market is segmented into Brazil, Argentina, and the Rest of South & Central America. Increasing in geriatric population in the region and increase in cases of acute pancreatitis is fueling the growth of the South & Central America acute pancreatitis market in the region. Acute pancreatitis is a life-threatening disease, especially in the geriatric population due to co-morbidities and compromised body systems. As per Brazil's Ministry of Health, by 2030, Brazil is anticipated to rank fifth in terms of geriatric population worldwide. The WHO estimated that the elderly population will have increased by more than 300% and the overall population will grow by 30% by 2050 in the country. According to Pan American Health Organization (PAHO), in 2022, Brazil had more than 30 million people aged above 60, which represents 30% of the total population. The number of people aged above 60 is expected to reach ~50 million, which is expected to represent 24% of the total population of Brazil by 2050. Apart from aging, alcohol consumption can also cause acute pancreatitis. According to an article published in Nature, 85.2% of the total alcohol drinkers were heavy drinkers in Brazil. Thus, the increase in alcohol consumption in Brazil is also fueling the growth of the South & Central America acute pancreatitis market.

South & Central America Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)

South & Central America Acute Pancreatitis Market Segmentation

The South & Central America acute pancreatitis market is segmented offerings, causes, end user, and country.

Based on offerings, the South & Central America acute pancreatitis market is segmented into medications, diagnosis, and others. The diagnosis segment held the largest market share in 2022.

Based on causes, the South & Central America acute pancreatitis market is segmented into gallstones, alcoholism, genetic disorders, infection, and others. The gallstones segment held the largest market share in 2022.

Based on end user, the South & Central America acute pancreatitis market is divided into hospitals, diagnostic laboratories, ambulatory surgical centres, and others. The hospitals segment held the largest market share in 2022.

Based on country, the South & Central America acute pancreatitis market is segmented into Brazil, Argentina, and the Rest of South & Central America. The Rest of South & Central America dominated the South & Central America acute pancreatitis market share in 2022.

Abbott Laboratories, Baxter International Inc, Boston Scientific Corp, Fresenius Kabi AG, GE HealthCare Technologies Inc, Koninklijke Philips NV, Medtronic Plc, and Samsung Healthcare are some of the leading companies operating in the South & Central America acute pancreatitis market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights
  • 2.2 South & Central America Acute Pancreatitis Market, by Country (US$ Million)

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. South & Central America Acute Pancreatitis Market Landscape

  • 4.1 Overview

5. South & Central America Acute Pancreatitis Market - Key Industry Dynamics

  • 5.1 Key Market Drivers
    • 5.1.1 Rise in Pancreatic Cancer Cases Due to Acute Pancreatitis
    • 5.1.2 Rising Incidence of Diabetes Following Acute Pancreatitis
  • 5.2 Key Market Restraints
    • 5.2.1 Side Effects of Pancreatitis and Pancreatic Cancer Treatments
  • 5.3 Key Market Opportunities
    • 5.3.1 Upsurge in Number of R&D Activities and Awareness Programs on Acute Pancreatitis
  • 5.4 Future Trends
    • 5.4.1 Advancements in Specific Acute Pancreatitis Treatments
  • 5.5 Impact Analysis:

6. Acute Pancreatitis Market - South & Central America Market Analysis

  • 6.1 South & Central America Acute Pancreatitis Market Revenue (US$ Mn), 2022 - 2030

7. South & Central America Acute Pancreatitis Market - Revenue and Forecast to 2030 - by Offerings

  • 7.1 Overview
  • 7.2 South & Central America Acute Pancreatitis Market Revenue Share, by Offerings, 2022 & 2030 (%)
  • 7.3 Medications
    • 7.3.1 Overview
    • 7.3.2 Medications: South & Central America Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
      • 7.3.2.1 South & Central America Acute Pancreatitis Market, by Medications, 2020-2030 (US$ Million)
  • 7.4 Diagnosis
    • 7.4.1 Overview
    • 7.4.2 Diagnosis: South & Central America Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
      • 7.4.2.1 South & Central America Acute Pancreatitis Market, by Diagnosis, 2020-2030 (US$ Million)
  • 7.5 Others
    • 7.5.1 Overview
    • 7.5.2 Others: South & Central America Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)

8. South & Central America Acute Pancreatitis Market - Revenue and Forecast to 2030 - by Causes

  • 8.1 Overview
  • 8.2 South & Central America Acute Pancreatitis Market Revenue Share, by Causes 2022 & 2030 (%)
  • 8.3 Gallstones
    • 8.3.1 Overview
    • 8.3.2 Gallstones: South & Central America Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Alcoholism
    • 8.4.1 Overview
    • 8.4.2 Alcoholism: South & Central America Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.5 Genetic Disorders
    • 8.5.1 Overview
    • 8.5.2 Genetic Disorders: South & Central America Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.6 Infections
    • 8.6.1 Overview
    • 8.6.2 Infections: South & Central America Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.7 Others
    • 8.7.1 Overview
    • 8.7.2 Others: South & Central America Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)

9. South & Central America Acute Pancreatitis Market - Revenue and Forecast to 2030 - by End User

  • 9.1 Overview
  • 9.2 South & Central America Acute Pancreatitis Market Revenue Share, by End User, 2022 & 2030 (%)
  • 9.3 Hospitals
    • 9.3.1 Overview
    • 9.3.2 Hospitals: South & Central America Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.4 Diagnostic Laboratories
    • 9.4.1 Overview
    • 9.4.2 Diagnostic Laboratories: South & Central America Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.5 Ambulatory Surgical Centers
    • 9.5.1 Overview
    • 9.5.2 Ambulatory Surgical Centers: South & Central America Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.6 Others
    • 9.6.1 Overview
    • 9.6.2 Others: South & Central America Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)

10. South & Central America Acute Pancreatitis Market - Country Analysis

  • 10.1 Overview
      • 10.1.1.1 South & Central America Acute Pancreatitis Market, by Country
      • 10.1.1.2 Brazil
        • 10.1.1.2.1 Overview
        • 10.1.1.2.2 Brazil: South & Central America Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.1.2.3 Brazil: South & Central America Acute Pancreatitis Market, by Offerings, 2020-2030 (US$ Million)
        • 10.1.1.2.3.1 Brazil: South & Central America Acute Pancreatitis Market, For Medications by Offerings, 2020-2030 (US$ Million)
        • 10.1.1.2.3.2 Brazil: South & Central America Acute Pancreatitis Market, For Diagnosis by Offerings, 2020-2030 (US$ Million)
        • 10.1.1.2.4 Brazil: South & Central America Acute Pancreatitis Market, by Causes, 2020-2030 (US$ Million)
        • 10.1.1.2.5 Brazil: South & Central America Acute Pancreatitis Market, by End User, 2020-2030 (US$ Million)
      • 10.1.1.3 Argentina
        • 10.1.1.3.1 Overview
        • 10.1.1.3.2 Argentina: South & Central America Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.1.3.3 Argentina: South & Central America Acute Pancreatitis Market, by Offerings, 2020-2030 (US$ Million)
        • 10.1.1.3.3.1 Argentina: South & Central America Acute Pancreatitis Market, For Medications by Offerings, 2020-2030 (US$ Million)
        • 10.1.1.3.3.2 Argentina: South & Central America Acute Pancreatitis Market, For Diagnosis by Offerings, 2020-2030 (US$ Million)
        • 10.1.1.3.4 Argentina: South & Central America Acute Pancreatitis Market, by Causes, 2020-2030 (US$ Million)
        • 10.1.1.3.5 Argentina: South & Central America Acute Pancreatitis Market, by End User, 2020-2030 (US$ Million)
      • 10.1.1.4 Rest of South & Central America
        • 10.1.1.4.1 Overview
        • 10.1.1.4.2 Rest of South & Central America: South & Central America Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.1.4.3 Rest of South & Central America: South & Central America Acute Pancreatitis Market, by Offerings, 2020-2030 (US$ Million)
        • 10.1.1.4.3.1 Rest of South & Central America: South & Central America Acute Pancreatitis Market, For Medications by Offerings, 2020-2030 (US$ Million)
        • 10.1.1.4.3.2 Rest of South & Central America: South & Central America Acute Pancreatitis Market, For Diagnosis by Offerings, 2020-2030 (US$ Million)
        • 10.1.1.4.4 Rest of South & Central America: South & Central America Acute Pancreatitis Market, by Causes, 2020-2030 (US$ Million)
        • 10.1.1.4.5 Rest of South & Central America: South & Central America Acute Pancreatitis Market, by End User, 2020-2030 (US$ Million)

11. South & Central America Acute Pancreatitis Market-Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies in the South & Central America Acute Pancreatitis Market
  • 11.3 Inorganic Growth Strategies
    • 11.3.1 Overview
  • 11.4 Organic Growth Strategies
    • 11.4.1 Overview

12. Company Profiles

  • 12.1 Abbott Laboratories
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 GE HealthCare Technologies Inc
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 Samsung Healthcare
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 Koninklijke Philips NV
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Baxter International Inc
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Medtronic Plc
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 Boston Scientific Corp
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 Fresenius Kabi AG
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments

13. Appendix

  • 13.1 About Us
  • 13.2 Glossary of Terms